Reaching the planned number of patients in clinical trials is a great success, but it is only the first step. The real challenge and the true measure of success lie in ensuring that these patients remain in the process until the end of the study (retention). A volunteer leaving the research early compromises data integrity, increases costs, and delays the delivery of innovative treatments to patients.
At Medisol Clinical Trial Services, we know that volunteers dropping out of a study is rarely due to medical reasons; rather, it often stems from operational challenges and a lack of communication. Therefore, by adopting a "patient-centric" approach, we develop strategies that minimize drop-out rates.
Why Does Patient Retention Drop?
Before diving into strategies, it is essential to understand why patients leave a study. The most common reasons include:
- Difficulty commuting to the research site and the associated loss of time.
- Expectations not being clearly communicated during the informed consent process.
- Study procedures (such as frequent blood draws or lengthy visits) severely disrupting the patient's daily life.
- A failure to establish a strong bond with the research team, leaving the volunteer feeling like merely a "data source."
Medisol's Strategies for Increasing Patient Retention
To keep the volunteers' belief and motivation in the study at the highest level, we implement the following core strategies in our operational processes:
Strong Site Team Support: The strongest anchor keeping a patient in a trial is the human connection they build with their physician and study nurse. At Medisol, our Clinical Research Associates (CRAs) take the bureaucratic load off the site staff, allowing them to dedicate more time and empathy to their patients.
Transparent and Realistic Expectation Management: Retention begins before the consent form is even signed. Patients are informed in the most transparent way possible—not only about the benefits of the study but also about visit frequencies, the physical demands of the procedures, and the potential impacts on their daily lives. A patient who encounters no surprises is far less likely to abandon the trial.
Alleviating Logistical and Financial Burdens: Patients should not bear a financial burden when choosing to contribute to science. At Medisol, we organize transportation (such as private transfer services) on visit days and ensure that out-of-pocket expenses, like travel and meals, are reimbursed without delay, making the process as effortless as possible for them.
Decentralized and Flexible Approaches: We leverage technology to reduce the burden of site visits. When a hospital visit is not strictly necessary, we bring the trial directly to the patient using flexible solutions like telemedicine (online consultations), electronic patient diaries (ePRO), wearable technologies, and home nursing services.
Continuous Communication and Appreciation: Patients are active partners in the process, not passive subjects. Providing regular updates about the study's progress (within confidentiality limits), making them feel supported, and reaching out to check on their health between visits significantly strengthens the bond of trust.
Seeing the Human Behind the Data
At Medisol ClinicaEvery single data point in a clinical trial represents a human being who has entrusted us with their time and their hope. At Medisol Clinical Trial Services, we believe that making our volunteers' lives easier and treating them with the utmost respect is the fundamental secret to a successful clinical operation. High-quality data can only be achieved with volunteers who feel safe, respected, and valued.